SS
RYTM icon

SBI Securities’s Rhythm Pharmaceuticals RYTM Stock Holding History

SBI Securities’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Sell
217
-85
-28% -$7.68K ﹤0.01% 1480
2026
Q1 		$26.3K Sell
302
-41
-12% -$3.99K ﹤0.01% 1341
2025
Q4 		$36.7K Buy
343
+145
+73% +$15.4K ﹤0.01% 1209
2025
Q3 		$20K Buy
198
+30
+18% +$2.79K ﹤0.01% 1451
2025
Q2 		$10.6K Sell
168
-298
-64% -$18.2K ﹤0.01% 1681
2025
Q1 		$24.7K Sell
466
-200
-30% -$11.1K ﹤0.01% 1250
2024
Q4 		$37.3K Buy
+666
New +$36.8K ﹤0.01% 1072

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SBI Securities's RYTM Position: Q2 2026 in Review

SBI Securities reduced its Rhythm Pharmaceuticals (RYTM) stake by 28% in Q2 2026, selling an estimated $7.68K and leaving 217 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

SBI Securities first reported a position in RYTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.3K in Q4 2024. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • SBI Securities held 217 shares of Rhythm Pharmaceuticals worth $24.1K as of Q2 2026.
  • SBI Securities sold 85 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $7.68K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1480 holding.
  • SBI Securities first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Rhythm Pharmaceuticals position peaked at $37.3K in Q4 2024.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.